COVID-19 Alaska Weekly Case Update: December 5 — December 11, 2021

Alaska Weekly Update

Alaska Department of Health & Social Services Weekly Case Update
December 5 — December 11, 2021

Low

Statewide transmission
Rt0.85

HIGH

Statewide alert status 175.3

LIMITED

Hospital
capacity

Intermediate

Test positivity
3.57%

66.8%
of Alaskans aged 5+ are vaccinated

Red- Rt >1.2
Orange- Rt 1-1.2 Yellow- Rt <1

7-day case rate per 100,000 population.

Red-  ≥100
Orange- 50-99.99
Yellow- 10-49.99
Blue- 0-9.99

 

Multiple facilities continue to have a high number of inpatients, which results in delays in admitting patients from emergency departments as well as other operational challenges.

Red->5%
Orange- 2-5%
Yellow- <2%

This includes people with at least one dose. Estimated AK population 5 and older of 680,580 from the AK Department of Labor & Workforce Development.

Case Trends

  • Alaska currently has the thirty-third highest number of cases in the last seven days per 100,000 population among the 50 states.
  • Hospital capacity has been strained during the Delta variant wave of COVID-19 such that in some hospitals, it may become difficult to care for everyone who needs care, even for non-COVID health concerns. Some care may need to be delayed, there may be long wait times, and hospital beds may not be available.  
    • Hospitalizations are continuing to occur in younger Alaskans, with the median age of persons hospitalized due to COVID-19 in 2021 being about 5 years younger than in 2020.
    • Among those hospitalized due to COVID-19 and with specimen collection dates from January 16, 2021 through December 11, 2021, unvaccinated and partially vaccinated patients had a median age 14 years younger than fully vaccinated patients.

  • Substantial or high levels of COVID-19 transmission are occurring throughout much of Alaska.
  • 1,413 cases were reported in Alaskans the week of December 5–December 11. This is a 13.0% decrease from the number of cases reported the week before and indicates a downward trajectory. The course of the COVID-19 pandemic is difficult to predict, and the pattern of declining cases may not be sustained in future weeks.  
  • In the three largest boroughs (Anchorage Municipality, Matanuska-Susitna Borough, and Fairbanks North Star Borough) the number of new COVID-19 cases appears to be continuing to decline. There is not a clear upwards or downwards trajectory in the Kenai Peninsula Borough or the City and Borough of Juneau.
  • Regardless of the trajectories, high levels of community transmission are widespread, and dozens of Alaskans are hospitalized with COVID each week.
  • The intensity of COVID-19 transmission varies substantially between communities outside the largest boroughs. COVID-19 cases are regularly reported from nearly all boroughs and census areas and some communities are experiencing widespread transmission.

COVID-19 Guidance

Take action now to help slow the spread of COVID-19 and preserve health care capacity.

  • Please get vaccinated if you haven’t already and get a booster dose if you are eligible (see below for more information). Currently available COVID vaccines will help protect you, your family, and your community against COVID-19.
  • Wearing a mask when in indoor public spaces regardless of vaccination status is an important step to take to slow the spread of COVID-19. Most Alaskans live in an area with substantial or high community transmission where this action is needed to protect your health and the health of others.
  • Continue to avoid crowds and practice social distancing – particularly when indoors.
  • Seek testing if you have any symptoms or have been exposed to an infected person. If you do test positive, isolate right away, and notify your contacts. Ask them to get tested and, if they are unvaccinated, to quarantine.
  • If you test positive and you’re at increased risk for severe COVID, obtain monoclonal antibody treatment. This has been shown to be an effective treatment for reducing the risk of hospitalization. This treatment works best when given early.
  • Persons at high risk include but are not limited to persons who are elderly, immunocompromised, obese, pregnant, or have certain chronic underlying medical conditions.

Borough/Census Area Alert Level Trends

  • Alert levels are based on the case counts over the past 7 days as well as the daily number of reported cases over the past 7 days per 100,000 population.
  • Alert levels have been changed to more closely mirror CDC’s community transmission indicator and are calculated by borough and census area, rather than by region.

Borough/Census Area

Alert Level
November 22

Alert Level
November 29

Alert Level
December 6

Alert Level
December 13

Count

Rate

Count

Rate

Count

Rate

Count

Rate

Anchorage Municipality

793

274.4

652

225.6

579

200.4

466

161.3

Fairbanks North Star Borough

289

297.5

211

217.2

144

148.2

91

93.7

Juneau City and Borough

49

154.2

60

188.8

59

185.7

63

198.3

Kenai Peninsula Borough

158

268.1

99

168.0

117

198.5

74

125.6

Matanuska-Susitna Region

407

379.3

340

316.9

286

266.5

217

202.2

Nome Census Area

112

1,146.5

80

818.9

65

665.4

58

593.7

North Slope Borough

54

552.7

35

358.2

12

122.8*

8

81.9*

Northwest Arctic Borough

103

1,358.3

70

923.1

74

975.9

35

461.6

Chugach Census Area

24

355.5

10

148.1*

4

**

1

**

Copper River Census Area

25

926.3

22

815.1

17

629.9*

7

259.4*

Denali Borough

7

387.6*

0

**

3

**

0

**

Southeast Fairbanks Census Area

9

129.7*

19

273.9*

4

**

8

115.3*

Yukon-Koyukuk Census Area

13

257.7*

8

158.6*

1

**

3

**

Haines Borough

1

**

1

**

3

**

0

**

Petersburg Borough

76

2,383.2

38

1,191.6

13

407.7*

3

**

Sitka City and Borough

10

117.3*

8

93.9*

10

117.3*

26

305.1

Skagway Municipality

0

**

0

**

2

**

1

**

Wrangell City and Borough

21

882.7

10

420.3*

4

**

1

**

Yakutat plus Hoonah-Angoon

9

339.9*

3

**

1

**

1

**

Ketchikan Gateway Borough

91

665.4

91

665.4

104

760.4

67

489.9

Prince of Wales-Hyder Census Area

24

394.1

3

**

23

377.7

13

213.5*

Bethel Census Area

204

1,141.7

129

722.0

79

442.1

40

223.9

Kusilvak Census Area

37

457.5

41

506.9

64

791.3

55

680.0

Aleutians East Borough

2

**

2

**

0

**

1

**

Aleutians West Census Area

2

**

4

**

1

**

2

**

Dillingham Census Area

13

272.4*

9

188.6*

23

481.9

13

272.4*

Kodiak Island Borough

16

126.9*

9

71.4*

13

103.1*

19

150.7*

Bristol Bay plus Lake and Peninsula

10

413.2*

4

**

10

413.2*

5

**

Statewide

2,559

351.1

1,958

268.6

1,715

235.3

1,278

175.3

*Rates based on <20 observations are statistically unreliable and should be used with caution.
**Rates based on <6 observations are not reported.

Vaccination Status

  • Anyone aged ≥5 years in Alaska is now eligible to receive a COVID-19 vaccine.
  • If you have received an initial dose of the Pfizer or Moderna COVID-19 vaccine, be sure to get your second dose too.
  • Everyone ≥18 years old who received the primary series of an mRNA (Pfizer or Moderna) COVID-19 vaccine ≥6 months ago should receive a booster dose.
  • For people who received the Janssen COVID-19 vaccine, a boosterdose (either the Janssen vaccine again or an mRNA vaccine) is recommended for anyone aged ≥18 years who was vaccinated ≥2 months ago.
  • Adolescents aged 16 and 17 who received the primary series of the Pfizer vaccine ≥6 months ago may receive a booster dose of the Pfizer vaccine.
  • Learn more about who should get a booster dose and to find COVID-19 vaccines near you at covidvax.alaska.gov.
  • CDC recommends that people with moderately to severely compromised immune systems receive an additional dose of mRNA COVID-19 vaccine at least 28 days after a second dose of an mRNA vaccine.
  • Vaccinated persons with immunocompromising conditions should discuss with their health care providers the need for additional personal protective measures.
  • To schedule your vaccine appointment visit covidvax.alaska.gov or call 907-646-3322.
  • To find clinics in your area you can visit vaccines.gov or text your zip code to GETVAX (438829) in English, or VACUNA (822862) for Spanish.
  • The Alaska vaccine dashboard is available online for the most up-to-date data.

Borough/Census Area Vaccination Coverage

This is the percent of Alaskans aged ≥5 years who received one or more doses of vaccine.

Borough/Census Area

December 13

Aleutians East Borough

95%

Aleutians West Census Area

74%

Anchorage Municipality

74%

Bethel Census Area

80%

Bristol Bay plus Lake and Peninsula

76%

Denali Borough

75%

Dillingham Census Area

63%

Fairbanks North Star Borough

66%

Haines Borough

72%

Juneau City and Borough

83%

Kenai Peninsula Borough

52%

Ketchikan Gateway Borough

70%

Kodiak Island Borough

72%

Kusilvak Census Area

80%

Matanuska-Susitna Borough

45%

Nome Census Area

81%

North Slope Borough

42%

Northwest Arctic Borough

66%

Petersburg Borough

68%

Prince of Wales-Hyder Census Area

69%

Sitka City and Borough

82%

Skagway Municipality

81%

Southeast Fairbanks Census Area

39%

Valdez-Cordova Census Area

65%

Wrangell City and Borough

65%

Yakutat plus Hoonah-Angoon

79%

Yukon-Koyukuk Census Area

82%

Statewide

66.8%

Note: Vaccination coverage estimates by borough and census area now include data on vaccines administered by the DoD and VA, which led to an increase in reported vaccination coverage for certain boroughs and census areas.  

New Hospitalizations and Deaths

  • Cumulative hospitalizations increased by 31 to 3,148. Hospitalization reports often lag when a case was initially reported.
  • 6.4% of hospitalized patients in Alaska had COVID-19 as of December 13, 2021.
  • On December 11th there were 66 persons with COVID-19 in AK hospitals, which is a 12% decrease relative to the week before when there were 75 persons hospitalized.
  • The cumulative number of COVID-19 deaths among Alaska residents increased by 4 to 857. It is common to take some time for a death to be reported and verified, and deaths that occurred during December 5–December 11 may be reported in the future after death certificates are reviewed.

Total Confirmed COVID Beds Occupied


Variant Tracking

The most recent Genomic Surveillance data can be found on the “COVID-19 Variants” tab of the Cases Dashboard.

Variants of Concern

Cases Identified

Change from Previous Report

First Identified in Alaska

Delta (B.1.617.2-like)

5,949

+257

30 May 2021

Omicron (B.1.1.529-like)

1

+1

29 November 2021

 

Variants Being Monitored

Cases Identified

Change from Previous Report

First Identified in Alaska

Alpha (B.1.1.7)

461

-2

20 December 2020

Beta (B.1.351)

7

0

20 March 2021

Epsilon (B.1.427/429)

139

0

24 December 2020

Eta (B.1.525)

1

0

16 March 2021

Gamma (P.1/P.1.1/P.1.2)

76

0

8 February 2021

Iota (B.1.526)

24

0

4 February 2021

Mu (B.1.621)

161

0

6 May 2021

Zeta (P.2)

4

0

27 January 2021

Vaccine Breakthrough Cases

  • Vaccine breakthrough (VB) infections of COVID-19 are those detected in a person who is at least 2 weeks beyond their second dose of a 2-dose series or the only dose of a 1-dose series.
  • Alaska residents who are fully vaccinated are much less likely to be hospitalized due to COVID-19 than those who are not fully vaccinated. (Age-standardized per capita rates of COVID-19 hospitalizations by vaccination status are updated monthly.)

  • The following updated VB data are among Alaska residents aged ≥5 years with a specimen collection date from January 16–December 11, 2021.
    • From January 16–December 11, 2021, 100 deaths, 317 hospitalizations, and 24,841 cases with a VB infection were reported among Alaska residents aged ≥5 years. These counts are provisional and subject to change as data are compiled and reviewed. In that same time frame, a total of 92,352 cases, 1,936 hospitalizations, and 546 deaths were reported.
    • 73% of all cases, 84% of all hospitalizations, and 82% of deaths among Alaska residents aged ≥5 years from January 16–December 11, 2021 were in people who were not fully vaccinated. 
    • More detailed information about hospitalizations, deaths, repeat and vaccine breakthrough infections among Alaska residents can also be found in the monthly report, which includes data through October.
    • Age-standardized per capita rates of COVID-19 cases by vaccination status are updated weekly. Some COVID-19 cases with specimen collection in the immediate past week (indicated by the grey box) may have not yet been reported or counted.

  • The following table shows by region the number of vaccine breakthrough cases and the number of cases among persons who are not fully vaccinated.

 

Cases (December 5–December 11)

Region

Vaccine breakthrough
(All ages)

Not fully vaccinated
(All ages)

Anchorage Municipality

144

264

Fairbanks North Star Borough

25

52

Juneau City and Borough

28

29

Kenai Peninsula Borough

20

49

Matanuska-Susitna Borough

57

125

Northwest Region

35

58

Other Interior Region

**

**

Other Southeast Region - Northern

13

15

Other Southeast Region - Southern

28

50

Southwest Region

10

20

Y-K Delta Region

45

48

**To protect privacy, data are excluded from rows in which any value is <5.

  • A variety of factors may affect the proportion of vaccine breakthrough cases by region. In communities with higher vaccination coverage, a larger proportion of cases is expected to occur among fully vaccinated persons. Other potential factors include the extent of prior infection in a region and differences in testing practices between regions.

COVID-19 Communication Resources

Statewide Percentage of Daily Tests with Positive Results
(Seven day rolling average)

Cases by Week of Onset and Age


Note: Quality assurance efforts are ongoing to attribute cases to the correct date on the onset date epi curve. Some recent cases will be reattributed to different weeks.

Cases by Week of Onset and Race


Note: Quality assurance efforts are ongoing to attribute cases to the correct date on the onset date epi curve. Some recent cases will be reattributed to different weeks. Race abbreviations include AI/AN (American Indian or Alaska Native), Asian/NHOPI (Asian, Native Hawaiian or Other Pacific Islander), and UI/Unknown (Under investigation or unknown).

Additional informational resources:

Additional ECHO session details:

Updated December 16, 2021

DHSS, UAA ECHO

These ECHO sessions are produced and facilitated by
UAA’s Center for Human Development Alaska ECHO project
in partnership with the State of Alaska, Department of Health & Social Services

Important Note: Most Division of Public Health ECHO series will be taking a break from December 20-December 31 for the winter holidays. Please check individual ECHO registration pages for additional information on holiday scheduling.

Regular Series

Alaska Medical Provider ECHO (formerly COVID-19 for AK Healthcare Providers)
Monthly on the 1st Tuesday of the month from 7-8 pm
This ECHO aims to increase knowledge and share best practices among medical providers across Alaska as well as to increase access to information for those living in rural areas of the state.

School Health ECHO
Every Monday from 3:00-4:00 p.m Register
The School Health ECHO is a virtual learning network intended for professionals in the education setting (administrators, school-based nurses, etc.) to interface with a team of medical and education experts in Alaska.

Vaccine ECHO for Providers
Weekly on Tuesday from 2-3 p.m. Register
The Vaccine ECHO for providers provides planning and operation updates to vaccine providers across Alaska, while answering any questions you may have.

Palliative Care ECHO
Monthly on the first Tuesday from 12-1 p.m.
This monthly ECHO is for all Alaskan healthcare disciplines supporting patients with serious illness, and aims to provide support and up-to-date information regarding Palliative Care during this period of COVID-19.

Public Science ECHO
Weekly on Wednesday from 12-1 p.m. register via Zoom
The Alaska Public Health Science ECHO is a virtual learning network intended for the general public to interface with our Public Health Leadership Team to explore the science of the COVID-19 virus, other public health topics, and current best practices. Or view via concurrent livestream to Facebook: https://www.facebook.com/akechoprograms

Local Government Public Health ECHO
Monthly on the third Wednesday from 3-4 p.m. Register
The Local Government Public Health Analysis ECHO is a virtual learning environment intended for local Alaska government leaders to interact with the State Public Health Leadership team and focuses on pandemic mitigation tools available, and how to use them.

Long Term Care Facilities ECHO 
Second Wednesday of the month from 4-5 p.m. Register 
Please join other staff and administrators of Alaska’s assisted living homes and residential care facilities to gather, learn, share, and grow. COVID has disrupted the fabric of our daily life and we can always learn from each other as we adjust to the new normal.

Healthcare Specific Situational Awareness ECHO
Weekly on Thursday from 12-1 p.m.  Register
The Healthcare Specific Situational ECHO is a virtual learning network intended for healthcare professionals to interface with our Public Health Leadership Team to explore current best practices and the most recent information related to Public Health.

Perinatal ECHO
Monthly on 3rd Thursday from 6-7 p.m. Register
The Alaska Perinatal ECHO is a virtual learning network intended for medical providers caring for pregnant patients and their newborns.

EMS ECHO
Monthly on the 1st and 3rd Wednesday 1-2 p.m Register
The EMS ECHO is a virtual learning network intended for Emergency Medical Services and related personnel in Alaska to amplify best practices. Sessions are topic-driven and typically include a guest presenter or a brief lecture with an interactive case or process discussion.

Co-Occurring Behavioral Health, Opioid and Stimulant Use Disorders ECHO
1st & 3rd Wednesdays from 12:00pm-1:00pm, November 3, 2021 - April 20, 2022
The Co-Occurring Behavioral Health (COBH), Opioid and Stimulant Use Disorders ECHO facilitates a virtual network for behavioral health providers to learn best practice care through real-time access to experienced subject matter experts and their peers. Each session includes a brief lecture, de-identified case presentation for participants to receive feedback on complex cases, and open discussion facilitated by an interdisciplinary team.

Data Waivers ECHO New ECHO!
2nd Wednesdays from 12:00pm-1:00pm, November 10, 2021 - September 14, 2022
The Data Waivers ECHO facilitates a virtual network for clinical providers to learn and implement best practices for offering buprenorphine and other medically assisted treatment (MAT) services under a data waiver. Each session includes a brief lecture, de-identified case presentation for participants to receive feedback on complex cases, and open discussion facilitated by an interdisciplinary team.

Session information and recordings of previous ECHO sessions
subscribe to ECHO calendar updates | email: echo@alaskachd.org | website: akecho.org